Article by: Tom Zuber and Carla Pareja Paris What Happened Last Week Last week at the FDA’s White Oak Campus, the agency’s Pharmacy Compounding Advisory Committee (PCAP) opened a two-day meeting to consider whether the seven popular peptides should be made easier to obtain through compounding pharmacies. The peptides on the agenda include BPC-157, KPV,…
Article by: Lonnie Rosenwald and Carla Pareja Paris Artificial intelligence has become central to the longevity industry. Companies increasingly rely on machine-learning models to analyze biomarkers, genomic data, wearable device outputs, and other health-related inputs to predict disease risk, biological age, or therapeutic response. Many tools, such as the new ChatGPT Health product, invite consumers…
Article by: Giorgia Giordani, Carla Pareja Paris, and Tom Zuber Montana has enacted a groundbreaking law that significantly expands access to experimental medical treatments, positioning the state as a potential hub for innovation—and controversy—in the healthcare sector. Senate Bill 535 (SB 535), signed into law by Governor Greg Gianforte in May 2025, authorizes the use…